Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.43 USD | -1.23% | +1.58% | -26.68% |
Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.68% | 949M | |
-18.52% | 131M | |
+7.32% | 60.9M | |
-15.34% | 61.96M | |
+0.60% | 52.2M |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.
- Earnings Flash (MDXG) MIMEDX GROUP Posts Q2 Revenue $66.9M